| 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers A Merlo, JG Herman, L Mao, DJ Lee, E Gabrielson, PC Burger, SB Baylin, ... Nature medicine 1 (7), 686-692, 1995 | 2557 | 1995 |
| Inactivation of the CDKN2/p16/MTS1 Gene Is Frequently Associated with Aberrant DNA Methylation in All Common Human Cancers JG Herman, A Merlo, LI Mao, RG Lapidus, JPJ Issa, NE Davidson, ... Cancer research 55 (20), 4525-4530, 1995 | 1958 | 1995 |
| The BATTLE trial: personalizing therapy for lung cancer ES Kim, RS Herbst, II Wistuba, JJ Lee, GR Blumenschein Jr, A Tsao, ... Cancer discovery 1 (1), 44-53, 2011 | 1021 | 2011 |
| Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck JA Brennan, L Mao, RH Hruban, JO Boyle, YJ Eby, WM Koch, ... New England Journal of Medicine 332 (7), 429-435, 1995 | 926 | 1995 |
| Frequency of homozygous deletion at p16/CDKN2 in primary human tumours P Cairns, TJ Polascik, Y Eby, K Tokino, J Califano, A Merlo, L Mao, ... Nature genetics 11 (2), 210-212, 1995 | 827 | 1995 |
| Rates of p16 (MTS1) Mutations in Primary Tumors with 9p Loss P Cairns, L Mao, A Merlo, DJ Lee, D Schwab, Y Eby, K Tokino, ... Science 265 (5170), 415-417, 1994 | 657 | 1994 |
| Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment L Mao, JS Lee, YH Fan, JY Ro, JG Batsakis, S Lippman, W Hittelman, ... Nature medicine 2 (6), 682-685, 1996 | 619 | 1996 |
| Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment L Mao, JS Lee, YH Fan, JY Ro, JG Batsakis, S Lippman, W Hittelman, ... Nature medicine 2 (6), 682-685, 1996 | 619 | 1996 |
| Predicting cancer development in oral leukoplakia: ten years of translational research JJ Lee, WK Hong, WN Hittelman, L Mao, R Lotan, DM Shin, SE Benner, ... Clinical Cancer Research 6 (5), 1702-1710, 2000 | 593 | 2000 |
| Microsatellite alterations as clonal markers for the detection of human cancer. L Mao, DJ Lee, MS Tockman, YS Erozan, F Askin, D Sidransky Proceedings of the National Academy of Sciences 91 (21), 9871-9875, 1994 | 589 | 1994 |
| Clonal genetic alterations in the lungs of current and former smokers L Mao, JS Lee, JM Kurie, YH Fan, SM Lippman, A Broxson, FR Khuri, ... Journal of the National Cancer Institute 89 (12), 857-862, 1997 | 570 | 1997 |
| Detection of oncogene mutations in sputum precedes diagnosis of lung cancer L Mao, RH Hruban, JO Boyle, M Tockman, D Sidransky Cancer research 54 (7), 1634-1637, 1994 | 542 | 1994 |
| Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation JC Soria, HY Lee, JI Lee, L Wang, JP Issa, BL Kemp, DD Liu, JM Kurie, ... Clinical Cancer Research 8 (5), 1178-1184, 2002 | 541 | 2002 |
| Molecular detection of primary bladder cancer by microsatellite analysis L Mao, MP Schoenberg, M Scicchitano, YS Erozan, A Merlo, D Schwab, ... Science 271 (5249), 659-662, 1996 | 523 | 1996 |
| Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer S Temam, H Kawaguchi, AK El-Naggar, J Jelinek, H Tang, DD Liu, ... Journal of Clinical Oncology 25 (16), 2164-2170, 2007 | 496 | 2007 |
| A Novel p16INK4A Transcript L Mao, A Merlo, G Bedi, GI Shapiro, CD Edwards, BJ Rollins, D Sidransky Cancer research 55 (14), 2995-2997, 1995 | 495 | 1995 |
| Focus on head and neck cancer L Mao, WK Hong, VA Papadimitrakopoulou Cancer cell 5 (4), 311-316, 2004 | 461 | 2004 |
| Transcriptomic dissection of tongue squamous cell carcinoma H Ye, T Yu, S Temam, BL Ziober, J Wang, JL Schwartz, L Mao, DT Wong, ... BMC genomics 9, 1-11, 2008 | 408 | 2008 |
| Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication JC Soria, SJ Jang, FR Khuri, K Hassan, D Liu, WK Hong, L Mao Cancer research 60 (15), 4000-4004, 2000 | 407 | 2000 |
| Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer X Tang, FR Khuri, JJ Lee, BL Kemp, D Liu, WK Hong, L Mao Journal of the National Cancer Institute 92 (18), 1511-1516, 2000 | 405 | 2000 |
Chao WangSenior Applied Researcher, MicrosoftAdresă de e-mail confirmată pe microsoft.com
